Journal List > Korean J Urol > v.49(12) > 1005029

Kim, Woo, Kim, Lee, and Kim: Laparoscopic Partial Nephrectomy: An Useful Method of Decision Making for Determining the Approach and Surgical Method Based on the Systematic Classification of Tumor Location

Abstract

Purpose

Laparoscopic patial nephrectomy is still one of challenging surgeries in laparoscopic urologic field and needs skillful technique of surgeons. When performing laparoscopic partial nephrectomy, initial plan of how to approach affects the whole course of the surgery. To propose a systematic decision guideline, we used the tumor location as the determining factor for selecting initial plan and analyzed our initial experience.

Materials and Methods

From September 2005 to April 2008, we performed 22 LPNs for small renal tumors less than 40mm in diameter, as measured from the preoperative computed tomography scans. We divided the tumor locations into 18 categories with the combinations of the anterior and posterior renal axes, and the upper, middle, lower parts of the kidney and the peripheral, central and hilar locations of the tumor. According to the tumor location categories, we performed LPNs through the retroperitoneal simple and complex approaches, and the transperitoneal simple and complex approaches.

Results

Twenty of twenty-two tumors (91%) were removed successfully through 4 different approaches, but 2 cases were converted to laparoscopic radical nephrectomies (LRNs). The mean operation time was 203 minutes, including a mean warm ischemic time (WIT) of 30.7 minutes. Among the 17 cases of RCC, 15 tumors were successfully removed via LPNs, and there were no cases with positive margins and no tumor recurrence during a mean of 14.9 months follow-up with a maximum follow-up period of 34 months.

Conclusions

Dividing the tumor location into 18 categories is useful for deciding on the appropriate laparoscopic approach.

References

1. Ljungberg B, Hanbury DC, Kuczyk MA, Merseburger AS, Mulders PF, Patard JJ, et al. Renal cell carcinoma guideline. Eur Urol. 2007; 51:1502–10.
crossref
2. Cockcroft DW, Gault MH. Prediction of creatinine clearance from serum creatinine. Nephron. 1976; 16:31–41.
crossref
3. Winfield HN, Donovan JF, Godet AS, Clayman RV. Laparo-scopic partial nephrectomy: initial case report for benign disease. J Endourol. 1993; 7:521–6.
crossref
4. Porpiglia F, Volpe A, Billia M, Scarpa RM. Laparoscopic versus open partial nephrectomy: analysis of the current literature. Eur Urol. 2008; 53:732–42.
crossref
5. Hong SH, Ryu KY, Yoo JS, Seo SI, Kim JC, Hwang TK. Laparoscopic partial nephrectomy for the 4cm or less renal tumors. Korean J Urol. 2006; 47:1256–62.
crossref
6. Seo IY, Bae BJ, Rim JS. Early experience of laparoscopic partial nephrectomy for renal tumor. Korean J Urol. 2007; 47:1–5.
crossref
7. Bang JK, Song C, Hong B, Park H, Kim CS, Ahn H. The effectiveness of simultaneous renal artery-vein clamping during laparoscopic partial nephrectomy on the surgical outcome. Korean J Urol. 2007; 47:897–902.
crossref
8. Herr HW. Partial nephrectomy for unilateral renal carcinoma and a normal contralateral kidney: 10-year followup. J Urol. 1999; 161:33–4.
crossref
9. Patard JJ, Shvarts O, Lam JS, Pantuck AJ, Kim HL, Ficarra V, et al. Safety and efficacy of partial nephrectomy for all T1 tumors based on an international multicenter experience. J Urol. 2004; 171:2181–5.
crossref
10. Becker F, Siemer S, Hack M, Humke U, Ziegler M, Stockle M. Excellent longterm cancer control with elective nephron-sparing surgery for selected renal cell carcinomas measuring more than 4cm. Eur Urol. 2006; 49:1058–63.
crossref
11. Steinbach F, Stockle M, Muller SC, Thuroff JW, Melchior SW, Stein R, et al. Conservative surgery of renal cell tumors in 140 patients: 21 years of experience. J Urol. 1992; 148:24–9.
crossref
12. Becker F, Siemer S, Humke U, Hack M, Ziegler M, Stockle M. Elective nephron sparing surgery should become standard treatment for small unilateral renal cell carcinoma: longterm survival data of 216 patients. Eur Urol. 2006; 49:308–13.
crossref
13. Pahernik S, Roos F, Hampel C, Gillitzer R, Melchior SW, Thuroff JW. Nephron sparing surgery for renal cell carcinoma with normal contralateral kidney: 25 years of experience. J Urol. 2006; 175:2027–31.
crossref
14. Thompson RH, Leibovich BC, Lohse CM, Zincke H, Blute ML. Complications of contemporary open nephron sparing surgery: a single institution experience. J Urol. 2005; 174:855–8.
crossref
15. Sutherland SE, Resnick MI, Maclennan GT, Goldman HB. Does the size of the surgical margin in partial nephrectomy for renal cell cancer really matter? J Urol. 2002; 167:61–4.
crossref
16. Porpiglia F, Volpe A, Billia M, Renard J, Scarpa RM. Assessment of risk factors for complications of laparoscopic partial nephrectomy. Eur Urol. 2008; 53:590–6.
crossref
17. Lerner SE, Hawkins CA, Blute ML, Grabner A, Wollen PC, Eickholt JT, et al. Disease outcome in patients with low stage renal cell carcinoma treated with nephron sparing or radical surgery. J Urol. 1996; 155:1868–73.
crossref
18. Lane BR, Gill IS. 5-year outcomes of laparoscopic partial nephrectomy. J Urol. 2007; 177:70–4.
crossref
19. Gill IS, Colombo JR Jr, Moinzadeh A, Finelli A, Ukimura O, Tucker K, et al. Laparoscopic partial nephrectomy in solitary kidney. J Urol. 2006; 175:454–8.
crossref

Fig. 1.
The representative preoperative computed tomography images. (A, B) Hilar tumor; the tumor mass comes close to the branches of the renal vessels and the renal pelvis. (C, D) Central tumor; the inner margin of the tumor approaches to the renal sinus fat.
kju-49-1067f1.tif
Table 1.
Patient characteristics
No. of patients 22
Age (mean, years) 60.7 (45–76)
Male:Female 16:6
Body mass index (mean, kg/m2) 25.6 (20.5–29.5)
Comorbidities 19 (86.4%)
Hypertension 11
Diabetes mellitus 7
Chronic obstructive pulmonary disease 1
History of stroke 2
History of acute myocardial infarction 1
Chronic kidney disease 1
Gastric cancer 2
Liver cirrhosis 2
Gall bladder stone 4
HBV carrier 1
Tumor size (mean, mm) 22.2 (12–39)
Tumor site  
Right:Left 13:9
Tumor locations  
Peripheral 11
Central 6
Hilar 5
No. solitary kidney 2 (synchronous RCC)
Preoperative Cr (mean, mg/dl) 1.04 (0.7–1.7)
Preoperative eCcr (mean, ccs/min) 71.67 (47.79–104.78)
Follow-up period (mean, months) 14.2 (3–34)

HBV: hepatitis B virus, Cr: creatinine, eCcr: estimated creatinine clearance rate, RCC: renal cell carcinoma

Table 2.
The operative results, complications and oncologic outcomes of the current study and the recent series in Korea
            Complications      
Author No. of patients Mean tumor size (mm) Operation time (min) Mean WIT (min) Mean EBL (ml) No. transfused (%) Urine leak (%) Conversion (%) Positive surgical margin (%) Local recurrence (%) Mean follow-up (months)
Current study 22 22.2 203 (86–360) 30.7 (17–47) 256 2 (9.1) 1 (4.5) 2 (9.1), LRN 0 0 14.9
Hong et al5 27 25 193 (120–300) 27.8 (15–43) 493 2 (7.4) 0 1, LRN 15∗ 0 11.4
Seo et al6 15 33 180.7 (110–360) 32.5 (23–50) NA 8 (60) 1 0 0 0 11.4
Bang et al7 56 20.8 208∗ (139–357) 34.4∗ (5–75) NA 8 (14.3) 2 1, OPN 0 NA 6.3

WIT: warm ischemic time, EBL: estimated blood loss, LRN: laparoscopic radical nephrectomy, OPN: open partial nephrectomy, NA: not available, ∗: calculated from the results of the literature,

: including benign tumors,

: results from 17 cases of renal cell carcinoma

Table 3.
The operative results and the differences of Cr and eCcr among the three groups according to the tumor location in 19 cases, with excluding 2 LRN cases and 1 calyceal diverticular
  Peripheral (n=10) Hilar (n=5) Central (n=4)
Operation time (mean±SE, min) 176.1±45.9 198.6±25.5 259.2±70.2∗
WIT (mean±SE, min) 29.6±8.4 26.6±2.3 41.2±6.7
EBL (mean±SE, ml) 213±184 175±86 456±301
ΔCr (mean±SE, mg/dl) −0.07±0.15 −0.02±0.13 0.03±0.19
ΔeCcr (mean±SE, ccs/min) 4.7±8.7 1.9±10.4 −1.8±15.5

Cr: creatinine, eCcr: estimated creatinine clearance rate, LRN: laparoscopic radical nephrectomy, SE: standard error, WIT: warm ischemic time, EBL: estimated blood loss. ∗: p-value<0.05 by Mann-Whitney test

TOOLS
Similar articles